TW209835B - - Google Patents
Download PDFInfo
- Publication number
- TW209835B TW209835B TW081100434A TW81100434A TW209835B TW 209835 B TW209835 B TW 209835B TW 081100434 A TW081100434 A TW 081100434A TW 81100434 A TW81100434 A TW 81100434A TW 209835 B TW209835 B TW 209835B
- Authority
- TW
- Taiwan
- Prior art keywords
- item
- oral
- composition
- water
- shen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 34
- 210000003296 saliva Anatomy 0.000 claims abstract description 10
- 239000003112 inhibitor Substances 0.000 claims abstract description 9
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 23
- -1 fluoride carbohydrate Chemical class 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 210000000214 mouth Anatomy 0.000 claims description 14
- 239000010703 silicon Substances 0.000 claims description 14
- 229910052710 silicon Inorganic materials 0.000 claims description 14
- 230000002272 anti-calculus Effects 0.000 claims description 13
- 239000004575 stone Substances 0.000 claims description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 11
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 7
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 7
- 235000011010 calcium phosphates Nutrition 0.000 claims description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 150000002739 metals Chemical class 0.000 claims description 5
- 239000000571 coke Substances 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 4
- 229910052716 thallium Inorganic materials 0.000 claims 3
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 claims 3
- 239000004698 Polyethylene Substances 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- 241000219112 Cucumis Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 238000000429 assembly Methods 0.000 claims 1
- 229910052789 astatine Inorganic materials 0.000 claims 1
- RYXHOMYVWAEKHL-UHFFFAOYSA-N astatine atom Chemical compound [At] RYXHOMYVWAEKHL-UHFFFAOYSA-N 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 229910052735 hafnium Inorganic materials 0.000 claims 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 claims 1
- 229940005740 hexametaphosphate Drugs 0.000 claims 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 1
- 229960004999 lycopene Drugs 0.000 claims 1
- 235000012661 lycopene Nutrition 0.000 claims 1
- 239000001751 lycopene Substances 0.000 claims 1
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 claims 1
- 229920001290 polyvinyl ester Polymers 0.000 claims 1
- 239000009600 shenyin Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 1
- 229920001567 vinyl ester resin Polymers 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 11
- 239000000606 toothpaste Substances 0.000 abstract description 11
- 229940034610 toothpaste Drugs 0.000 abstract description 10
- 229920000388 Polyphosphate Polymers 0.000 abstract description 9
- 239000001205 polyphosphate Substances 0.000 abstract description 9
- 235000011176 polyphosphates Nutrition 0.000 abstract description 9
- 239000000843 powder Substances 0.000 abstract description 9
- 229920002554 vinyl polymer Polymers 0.000 abstract description 9
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 abstract description 8
- 239000002324 mouth wash Substances 0.000 abstract description 6
- 239000006071 cream Substances 0.000 abstract description 5
- 229940051866 mouthwash Drugs 0.000 abstract description 5
- 235000015218 chewing gum Nutrition 0.000 abstract description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000007937 lozenge Substances 0.000 abstract description 3
- 229940112822 chewing gum Drugs 0.000 abstract description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 20
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 13
- 235000011180 diphosphates Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 11
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 235000021317 phosphate Nutrition 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- 229940048084 pyrophosphate Drugs 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 125000000129 anionic group Chemical group 0.000 description 7
- 229940091249 fluoride supplement Drugs 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000011007 phosphoric acid Nutrition 0.000 description 6
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 6
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000002079 cooperative effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 5
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- BNKAXGCRDYRABM-UHFFFAOYSA-N ethenyl dihydrogen phosphate Chemical compound OP(O)(=O)OC=C BNKAXGCRDYRABM-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 3
- 235000019832 sodium triphosphate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000010692 aromatic oil Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229940094522 laponite Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VAXCXSDAWONRLI-UHFFFAOYSA-N 2,3-dihydroxypropyl hydrogen sulfate Chemical class OCC(O)COS(O)(=O)=O VAXCXSDAWONRLI-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- HCJMNOSIAGSZBM-UHFFFAOYSA-N 6-methylsalicylic acid Chemical compound CC1=CC=CC(O)=C1C(O)=O HCJMNOSIAGSZBM-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229910021593 Copper(I) fluoride Inorganic materials 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 1
- 240000002609 Pyrus pyrifolia var. culta Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000005572 Syzygium cordatum Species 0.000 description 1
- 235000006650 Syzygium cordatum Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical class [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- NOBTYUUWOBTGLI-UHFFFAOYSA-L difluoroaluminum Chemical compound F[Al]F NOBTYUUWOBTGLI-UHFFFAOYSA-L 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000423 heterosexual effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910001506 inorganic fluoride Inorganic materials 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- 229910001512 metal fluoride Inorganic materials 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000010661 oregano oil Substances 0.000 description 1
- 229940111617 oregano oil Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 150000003258 radon compounds Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- LFQULJPVXNYWAG-UHFFFAOYSA-N sodium;phenylmethanolate Chemical compound [Na]OCC1=CC=CC=C1 LFQULJPVXNYWAG-UHFFFAOYSA-N 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical class [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical group [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004846 x-ray emission Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dental Preparations (AREA)
- Confectionery (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Description
209835 Λ 6 Π 6 經濟部屮央標準局Κ3:工消伢合作杜印製 五、發明説明(/) 本發明相關於含有一防結合劑之口腔用組成物。 結合為形成於牙齒上之堅硬,礦物化組成。規律的 刷牙對預防這些累積物之快速堆積有幫肋,但即使規律 的刷牙不足以去除所有附箸於牙齒之之結石累積物。當 磷酸酸鈣結晶開始堆積在齒斑表面及細胞外間質時可形 成結石且成為緊密嵌合地集結而難以去除。對於鈣與正 磷酸最後會形成稱為羥基磷灰石(HAP)之結晶性物質之 途徑並無一致的定論。然而,漸為人接受的是在較高飽 和度時,即高於飽和上限時,結晶物HAP之先軀物為無 固定形狀或微結晶之磷酸鈣。”無固定形狀磷酸鈣”雖 然與羥基磷灰石相關卻與其原子結構,顆粒外形及立體 化學方面不同。無固定形狀磷酸鈣之X射線嬈射形態顯 示無固定形典型之廣吸收波,其缺乏包HAP之所有結晶 物之長範圍原子次序之特激。很明顯的,因此有效干擾 H A P結晶生成之因乎將有效作為防結石劑。本發明防結 石劑抑制結石形成之建議機轉可能牽涉活化能障的增加 ,因而抑制先軀物無固定晶形磷酸鈣轉變成HAP。 研究顯示在試管中一化合物防止HAP結晶生成之能 力與其在體内防止鈣化的能力有良好之關聯,而假設此 物質對唾液及其成分具惰性且穩定存在。 在此技g中己知水溶性六偏磷酸類,三聚磷酸類及 焦磷酸類及類似物為有效之鈣與鎂離子抑制劑,壓抑劑 (請先閲讀背而之注意事項洱填寫本頁) 裝· 訂_ 線- 本紙张尺度逍用中a B家樣準(CNS)T4規格(210x297公it) a0 c c 經濟部屮央榀準局Μ工消赀合作社印製
Jinrotrcr- 五、發明説明(,) ,扣押劑且/或箝形劑,且在試管中為HAP形成之有效 抑制劑,美國專利第4,515, 772號,1985年7月5日, Barran等人掲露且宣稱包含氟離子來源及可溶性齡金屬 之焦磷酸化物之口腔用防結石物質。先前技藝承認之大 量數目卷宗及在此專利中”引用之文獻”指出迄今於口 腔用物質中提出之聚磷酸類之許多用途及功能。 然而,如部分掲露於前述專利及如美國專利第 4, 627,877號,1986年11月9日,Gaffar等人及美國專利 第4,806,340號,1989年2月21日,Gaffar等人所顯示, 長_狀分子之去水聚磷酸類(即六偏磷酸類,三聚磷酸 類,焦磷酸類,等)通常進入口腔且/或唾液時會被唾 液酶(去磷酸酶)明顯水解成不能作為H A P形成抑制劑 之正磷酸。 在美國專利第4 , 6 2 7 , 9 7 7及4 , 8 0 6 , 3 4 0號,多元聚羧 酸及一氟離子來源可成功地作為克服藉唾液中去磷酸酶 對線狀分子之去水聚磷酸防結石劑之水解之用途。因此 ,聚羧酸抑制鹼性去磷酸酶之焦磷酸水解作用;氟離子 來源抑制藉酸性去磷酸酶或焦磷酸酶之焦磷酸水解作用 本發明目的在於更有效抑制唾液酶對於具非聚羧酸 多元體之聚磷酸防結石劑之作用。 本發明的另一目的偽提供一抑制結石形成之改良方 本紙尺度边用中國國家標準(CNS)T4規怙(210x297公;«:) 81. 2. 20,000 (請先閲請背而之注意事項#堝窍^ >.) 裝- 訂* 線·
Λ 6 \\G 209835 五、發明説明(七) 法。 (請先閲請背而之注意事項朴堝寫一厶 其他目的及優點見於下列過程敘述。 與此方面所確信的相符的是,本發明相關於包含在 一口服上可接受載體中至少具一線狀分子去水聚磷酸鹽 作為基本抗結劑之有效抗結石劑量,及已述之合成陰離 子聚磷酸乙烯酯在唾液中高逹4¾時免於受到酵素性水解 之有效抑制劑劑量之口服成分,合成性陰離子聚磷酸乙 烯酯具重複性基圃且其平均分子量約1〇〇〇或更多;其中 Μ及Μ為氫,鹼金屬 -C Η2 - C Η ~ MO - Ρ = 0 0Μ 或銨,且Μ及Μ為相同或相異。 此聚磷酸乙烯酯類之分子量由黏度或光線散射法測 量而得到。合成性陰離子聚磷酸乙烯酯先前已掲露可作 為抗結合劑而見於美國專利第3 , 4 2 9 , 9 6 3號,S h e a 1 1 ο ν s k y 。然而,此專利未掲露此聚磷酸乙烯酯作為抑制線狀聚 磷酸物之唾液性水解之用途。 經濟部屮央榣準/0CX工消费合作社印製 線狀分子去水聚磷酸鹽類,如六偏磷酸鹽類,三聚 磷酸鹽類及焦磷酸類,其已熟知為抗結合劑,通常以其 整體或部分中和之水溶性鹼金屬(例鉀或鈉)或銨鹽, 及上逑之任何混合物之形式使用。代表性實例包括六偏 83. 2. 20,000 本紙張尺度边用中國Η家榣準(CNS) 規格(210x297公货) 209835 Λ 6 Π 6 經?ίζ:部屮央櫺準而只工消伢合作杜印製 五、發明説明() ' 磷酸納,之聚磷酸納,焦磷二酸二鈉,焦磷酸三納,及 焦磷酸四鈉及類似物;例如可包含約2至125個磷原子 之線性分子去水磷酸發類。其通常在即溶性口腔用成分 中使用0.1至7%之適當重量百分比,偏好約2至6%, 如上述,這些鹽類在美國專利第4,627,977號及4,806,340 號中被掲露為抗結石劑。 當使用之焦磷酸鹽為其偏好使用之焦磷酸四鉀及焦 磷酸四納之混合物時,以焦磷酸四鉀佔主要份量。當僅 使用焦磷酸四納時,仍有一些會難溶,因而使得,口腔 用成分在外觀及烕覔上呈現顆粒狀。因此,當使用焦磷 酸四.鉀及焦磷酸四納之混合物重量約4. 3至7%之《好組 合時,焦磷酸四鈉發佔主要份量且粒狀物随即減少。四 鉀鹽——四鈉鹽之偏好比例由約4 . 3 : 2 . 7至約6 : 1 ,特別是 4.5: 1.5之比例。可依需要而出現約4.3%至U之單獨焦 磷酸四鉀或加上達2.7¾之焦磷酸四鈉,在另一偏好之具 體事實中焦磷酸四納之少量有效防結石劑量,如約0.1 至2%重量被加以使用且有效地被溶解。本發明亦包括 使用雙齡金屬之焦磷酸化物,例如約0.1%至約0.4%或 有需要時可用約1 %重置之劑量。 聚磷酸乙烯酯可以其水溶性酸形式,或鹽類(含酸 式锂)形式出現。鹽類包括鹼金屬,特別是納或鉀,或 (請先閲讀背而之注意事項洱塡寫本頁) 裝. 線' 本紙張尺度边用中a困家標準(CNS) ΤΜ規格(210X297公釐) Λ 6 η 6 209835 五、發明説明(Γ) (請先閲讀背而之注意事項/f堝寫本頁) 水溶性銨鹽。聚合物具一平均分子量至少約1000,典型 為約1000至10,〇〇〇且最偏好約6000至約10,000。其可依 此技藝中所熟知之技巧而藉自由基聚合由氣化磷酸乙烯 酯聚合而成。使用的磷酸聚乙烯酯劑量足以有效抑制高 逹43:重置之線狀分子去水聚磷酸鹽之酵素性唾液水解作 用。其通常在成分中使用〇.〇5至4%之合適重量百分比 ,通常約0.05至3%,熇好0.05至2%,較偏好0.1至 2%之重量。至少約1 %之重量百分率為典型被使用於 牙膏成分中,有意義之口服成分通常包含一牙齒磨料且 連同刷牙時一起使用,例包合膠質及乳霜之牙膏以及粉 末。超過4%重量可用來作為加厚或膠化之目的。 除了藉鹼性唾液去磷酸酶水解焦磷酸之聚磷酸乙烯 酯抑制劑外,另外一種水解作用之抑制是藉一氟離子來 源抑制藉由酸性去磷酸酶及唾液去焦磷酸酶之水解作用 而達成。此物質偏好出現且亦作為減少齲齒形成之用途 Ο 經濟部中央榣準局ΙΞ:工消ίϊ>合作杜印製 氟離子之來源,或提供氟之化合物,其可與一酵素 抑制劑一起出現,為此技蕤所熟知作為抗齲齒劑且亦作 為本發明使用中同樣之藥劑。這些化合物可稍撤溶於水 或完全為水溶性。其特性為其釋出氟離子於水中之能力 及其藉由與其他口腔用製備物之化合物在不期望之反應 中釋出。這些物質為無機氟鹽,如可溶性齡金屬,齡土 本紙张尺度边和中a Η家榀準CNS)肀4規怙(210x2976*) 209835 Λ 6 Π 6 經濟部+央榀準局貝工消#合作杜印製 五、發明説明(/) 金屬鹽類,例如,氟化納,氣化鉀,氟化銨,氟化鈣, 一種銅之氟化物如氟化亞銅或氟化鋅,氟化親,氟矽酸 鈉,氟矽酸銨,氟結酸鈉,單氟磷酸鈉,單及二氟磷酸 鋁,及氟化焦磷酸鈉鈣。錫之氟化物及特別之鹸金屬氟 化物類,如氟化鈉,和單氟磷酸UFP)鐮金屬,如偏好 NaMFP及上述之混合物。 提供氟化合物之含量依據其化合物種類,其溶解度及 口腔用製備物種類而定,但其化為無毒性之劑量,通常 在製備物中約0.005至約30%。在一牙音製備物中,例 膠質,乳霜,牙膏或牙粉,可釋出逹2000 ppb氟離子之 化合物重置比例被認為是令人滿意的。任何合適最低量 之化合物均可使用,但其偏好使用釋出300至2000 ppm 之足量化合物,特別偏好約800至15G0PP1D之氟離子。典 型上若為鹸金羼之氟化物及錫之氟化物,此成分劑量逹 2%重量,偽基於製備物之重量,且偏好0.05%至1 % 之範圍。若為單氟磷酸鈉,此化合物出現量約0.1至3% ,較典型約0.7 6%之重董百分比率。 在口腔用製備物如漱口水,糖衣錠及口香糖中,若 存在提供氟之化合物,則典型地含有足以釋出達5 0 0 ppb ,偏好約25至約3 0 0 ppb氟離子之份量。通常約在此化合 物0.005至約1.0%之重董。 在本發明一些高度偏好之形式中口腔用製備物本質 (請先閲讀背而之注意事項再填寫本頁) 裝· 訂- 線- 本紙ft尺度逍用中Η Η家標準(CNS) T4規格(210x297公龙) 209835 A 6 η 6 經浒部屮央梂準劝β工消费合作社印31 五、發明説叫(^) 上可為液體,如漱口水或濕潤劑。在這樣的製備物中, 載體典型為需要包含如下敘述之濕潤劑的水一乙酵混合 物。通常,水對乙醇的重量比例範圍由約1: 1至約20:1 ,偏好約2 : 1至約10: 1且較偏好約4 : 1至約6: 1 。在此形式製備物中水一乙酵混合物總蛋典型地在製備 物重量中佔有約70%至約99.9%之範圍。 本發明之此液體及其他製備物之PH通常在約4.5至9 之範圍中且典型地由約.5.5至8。pH偏好在約6至8.0範 圍中。值得注意的是本發明之成分可於PH低於5時口腔 施用而没有實質上去鈣化或其他損壞牙齒琺瑯情形發生 。PH可用酸(例檸檬酸或苄酸)或齡(例氫氣化鈉)或 缓衝液(如用檸樺酸鈉,苄酸物,硕酸物,或磺酸氫化 物,磷酸氫二納、磷酸氫納等)加以控制。 在本發明一些其他霈要的形式中,口腔用成分之實 質上待擞為固體或帝狀物,例牙粉,牙錠或牙膏(包括 膠質或牙霜)。此固體或資狀口腔用製備物之載髖通常 包含一牙齒可接受之水溶性亮光物質。亮光物質之實例 為水溶性偏磷酸納,偏磷酸鉀,磷酸鈣,二水磷酸二鈣 、無水磷酸二鈣、焦磷酸鈣、正磷酸鎂、磷酸三鎂、硪 酸鈣、矽酸鋁、矽酸結、含矽之光亮劑、膨潤土,及上 述之混合物。其他合適之亮光物質包括在1962年12月15 (請先閲讀背而之注意事項#填寫本頁) 裝. 訂· 線. 本紙張尺度边用中Β Η家標毕(CNS)T4規格(2丨0x297公楚) £09835 Λ 6 η 6 經濟部屮央櫺準而CX工消伢合作社印製 五、發明説明(g) 日之美國專利第3·070,510號中描述之粒狀如加熱永久成 型樹脂,加三聚氱胺,酚醛類,及脲甲醛•及交互連接 的聚琛氣物及聚酯類。偏好之光亮物質包括具逹約5撖 米大小之顆粒之矽晶,平均顆粒大小約1.1微米,且表 面積達5 0,0 0 0平方公分/克,矽願或膠態矽,及矽酸鋁 齡金屬無晶形複合物。 當痛要視覺上之清潔時,使用透明或不透明凝膠作 為謬態矽之含矽光亮劑,加以SYL0ID為商樣之Syltiid72 及 S y 1 〇 i d 7 4 ,以 Z e 〇 d e n t 為商標之 Z e 〇 d e n t 11 3 及 Z e 〇 d β n t 115或以SANTOCEL為商標之Santocel 100及矽酸鋁_金 颶複合物或含結合鋁之矽氣化物,如Ζβ〇49Α或Zeo 49B ,為特別的有用,因為其具有接近牙膏中常用的水或濕 潤糸統之反光偽數。 許多所謂之”不溶於水”之光亮物質之待撖為陰離 子性且亦含少置可溶性物質。因此,不溶性偏磷酸鈉可 用任何藉應用化學Thorpe’s字典第9冊,第4販510至 511頁中所示範之合適方式形成。不溶性偏磷酸鈉之形 式如所知的Madrell’s鹽及Kurrol’s®為合適物質之進 一步實例。這些傾磷酸鹽在水中只有很小的可溶性,且 因此常指不溶性偏磷酸鹽類(IMP)。此中出現之少董可 溶性磷酸物質為不純物,通常逹重量百分率4¾。不溶 -10 - (請先閲讀背而之注意事項洱填寫本頁) 裝- 訂_ 線- 本紙Λ尺A边用中《«家猱毕(CNS) Ή規怙(210x297公*) Λ 6 η 6 209835 五、發明説明(Ί) . ,(請先閲讀背而之注意事項再項寫本頁) 性磷酸馥類,其被相信在不溶性偏磷酸鹽情形下包括可 溶性之偏磷酸納,若需要可葙水清洗以減少或去除其含 量。典型使用之不溶性龄金屬之僱磷酸化物為粉末形式 而其中不超過1 %之物質之顆粒大小超過37撖米。 光亮物質通常以固體或資狀組成出現而佔重量潘度 約1 0 %至約9 9 %。偏好在牙音中含量範圍由約1 〇 3:至7 5 χ ,且在牙粉中由約70%至約99^。 在牙膏中,液狀載劑可典型地包含水及添潤劑而含 量範圍由製備物重量之約10%至約90%。甘油,丙二醚 ,山梨醇,聚丙二醇及/或聚乙二醇(例4 0 0 — 6 0 0 )為 實例中合適之濕潤載劑。液體含水、甘油及山梨酵之混 合物亦為有利的。在清潔凝膠中反光偽數為重要之考量 ,偏好使用約3 - 30重量%之水,0至約80重量%之甘 油,及約20-80重量%之山梨醇。 經濟部屮央標準局只工消伢合作社印製 牙膏(包括冷霜及凝膠)典型地包含一自然或合成 之增厚劑或膠化劑而以約0.1%至約10%之比例,偏好 約重量百分率0.5S:至53;。合適增厚劑為合成之hectorite ,一合成之膠態,矽酸鎂»金屬複合物箝形劑為可用的 ,例如 Laponite (例 CP, SP2002, D)而由 Laporle 工業 有限公司銷售,Laponite D之分析顯示,其成份重量百 分率為58. 00%之二氣化矽,25.40%之氣化鎂3.05涔之 氣化納,0.98%之氣化鋰及一些水和撖量金屬類。其真 -1 1 - 本紙張尺度边用肀國囤家iS準(CNS) <P4規格(2]0χ297公釐) 209835 Λ 6 Η 6 經濟部屮央標準局A工消费合作杜印51 五、發明説明(丨夕) , 實持異性重疫為2.53且其具1.0之明顯之體積密度1克 /毫升,於湄度8%時)。 其他合適之膠化劑包括愛爾蘭苔、山羊剌樹謬,毅 粉,聚乙烯吡咯酮,羥基乙基丙基鐵維,羥基丁基甲基 壤維,羥基丙基甲基雄維.羥基乙基纖維(例,Natrosol 為可用的),羧基甲基雄維納,XanthaB及睡態矽氣化 物如撖細粉末Syloid (例2 4 4 )。如先前所提,合成之 陰離子聚乙烯磷酸物亦可提供增厚或騵化之特性。醪態 矽氧化物如撖細粉末Syloid (例244)亦為合適之增厚 劑。 可加以瞭解的是,如傅统式的,口腔用製備物以合 適檫示之包裝加以販賣或其他運銷。因此一罐口腔潤溼 劑將有描述它的標示,在成分方面,如一 口腔潤溼剤或 漱口藥水且具其使用之指示;並且一牙膏,牙霜或凝隳 通常在可毅損之管子中,典型為鋁,薄鉛或塑謬製,或 其他壓擠材料,以壓縮或®力喷頭擠出内含物,其具標 示之説明,在成分方面,如同一牙膏,凝謬或牙箱。 有機界面活性劑被使用於本發明的組成中以逹到增 強預防之作用,》助使抗結石劑充分且完整地分佈於整 値口腔,且即溶性成分使得分觀上更能接受。有機界面 活性物質僱好陰離子性、無離子性或天然為脂性的,且 -12 - (請先閱讀背而之注意事項#蜞寫本頁) 本紙张尺度边用中a Η家炫準(CNS) >P4規格(210x297公釐) 209835 Λ 6 η 6 五、發明説明(丨1) 經济部十央標準局Ε3:工消"合作杜印製 (請先閲讀背而之注意事項#项寫本頁) 其偏好使用可使成分有清潔及起泡沫之特性之清潔性物 質作為界面活性劑。合適之陰離子界面剤實例為較力2 單硫酸單甘油醛化牌肪酸之水溶性鹽類,如氫化椰油脂 肪酸之單硫酸單甘油醒納鹽,1,2 -二羥基丙烷砚基之較 大烷基碾乙基酯較大脂肪酸酯,及較小兩性胺基羧酸化 合物之本質上飽和之較大兩性酸胺類加具12至16艏碩之 脂肪酸,烷基或醛基,及類似物。最後提及之醯胺類之 實例為Ν-月桂酵肉胺酸,及實質上會由肥皂或類似較脂 肪酸物質中釋出之Ν-月桂醯基,Ν-肉豆寇醴基,或Ν-棕 梠酸基肉胺酸之鈉、鉀,及乙烯胺强頰。這些肉胺酸化 合物使用於本質發明之口腔用成分中為特別有利的,因 這些物質表現延長及顳著的效果於抑制口腔中由於联水 化合物分解而産生的酸類之上且附加地使牙齒班Κ質在 酸溶液中溶解度減少一些。水溶性非雜子界面劑之實例 為具不同反應性含氳化合物之氧化乙烯之縮合物故具厭 水性1鍵(例,約12至2(ΗΤ确原子之脂肪鍵),其缩合 産物r’ethoxamers”)含親水性聚氣乙烯基圃例具胞肪 酸,脂肪醇.脂肪醯胺,多氫酵(例簞硬丨旨酸 脱水山 梨酵及聚氧化丙烯(例block copolyBer plur〇nic物質) 之聚(氣化乙烯)之縮合産物。 其他物質也可以加入本發明之口腔用物& 潔白劑,防腐劑,矽氣化物,蕖綠素化合物,其他抗結 -13 - 本紙Λ尺度遑用中Η 8家標毕(CNS) Τ4規怙(210x297公釐) 209835 Λ β Ιϊ 6 五、發明説明(〆) 石劑,及/或胺化物質如尿素,磷酸二銨,及上述混合 物。這些佐劑若存在,其加入製備物之含董不可實質上 負面影堪到需要之特性及特擻。可與本發明之活性成分 形成複合物之顯著下鋅、鎂及其他金颶鹽類及物質之含 量最好能避免。 可使用任何合適的芳香劑或甜味物質。合適芳香成 分之實例為芳香油,例矛形薄Μ油,薄荷油,冬緣油, 黃樟油,丁香油,紫蘇花油,桉樹油,甘牛至油,肉桂 酮,檸樣油及桔油,及甲基水揚酸。合適的甜味劑包括 蔗糖,乳糖,甘露糖,山梨糖·木糖,SootiUBl cyclamate, perillartine, APH (天門冬酵基苯基丙胺 酸,甲基酯),糖精及類似物。芳香劑和甜味劑很合適 共同包括由約0.1%至5%之製備物或更多。 在本發明偏好施用中一根據本發明之口腔用成分如 漱口藥水或牙莆所含已述之聚磷酸物及抑制劑以有效抑 制齒表結石之份置聯合而偏好規律施用在牙齒琺瑯質上 ,如每二天或三天一次或偏好每日1至3次,於約PH4.5 (請先閲讀背而之注意事項#埙寫本頁) _ 線· 經濟部屮央榀準局KX工消费合作社印製 8 至 2 少 至 8 至 6 約 好 偏 8 至 5 5 ο 約生 Η Ρ 終 常達 通久 .更 9 或 至週 他 , 其表 或外 糖原 香膠 口在 於裹 或包 ,或 中中 劑原 鍵 0 入熱 加溫 被入 可進 分動 成攪 之藉 明例 發 , 本中 品 産
4 1A 本紙张尺度边用中B國家標準(CNS)T4規格(210x297公;Jt) Λ (ί20Β&25_^ 五、發明説明(丨>) 經濟部中央櫺準>tjts:工消合作社印製 需物 ,合 等化 脂水 樹磺 成或 合劑 , 味 L ^3 § S 膠他 ,其 ne或 to糖 U Ti , 6 _ j 劑 之軟 述柔 已或 為劑 可塑 物之 範統 示傳 其要 本 是 的 解 瞭 可 但 性 特 之 〇 明 物發 似本 類範 及示 醇而 梨進 山例 ,實 糖列 萄下 0 如 申度 上溫 加且 附古口 及而’ 此量 在重 有就 所傜 , 率 示分 指百 有及 S量 非含 除之 c 稱 此指 於中 。 限圍氏 受範攝 不利為 明專位 發請單 (請先閲請背而之注意事項#堝寫41,^) 裝· 訂_ 線' 本紙張尺度边用中a困家«準(CNS) TM規格(2丨0X297公;«:) 81. 2. 20,000 209835 λ 6 __nj_ ? i 五、發明説明(、ψ) 實例1 : 以PVPA及PVMEMA抑制螓性去磷酸酶 製備含大腸菌驗性去磷酸酶於總睦積0.5毫升,具 100¾莫耳體積濃度Tris-Hcl緩衝液,PH8.0之反應混合 物,其中焦磷酸四納最终濃度為0.5毫其耳體積濃度。 此反應於焦磷酸加入後於37T:作用不同之時間。磷酸 乙烯酯,分子量l〇,〇〇〇(PVPA),或多元聚羧酸,聚乙烯 甲醚/蘋果酸酣而由GAF公司製備如 Gantrez S - 97 (PVME/MA),其已報告具分子置約70,000(藉蒸氣壓滲透 計;但藉凝膠滲透色層分析決定時其分子量約1,090,000) ,其PH於其以0.5%加入反應混合物之前已先調至8.0。 此反應藉加入0.5毫升之20%冷三氣醋酸(TCA)加以終止 。正磷酸釋出量發表於下表1中且計算如下: 對於每莫耳被水解之焦磷酸離子(PPi),根據公式 有2莫耳正磷酸釋出: 分子量 基於重S ,水解之PPi (克)=-xP〇4産生量(克) (請先閲讀背而之注意事項#項寫本頁) 經濟部屮央梂準而员工消"合作社印製 量 子 分 04 本紙张尺度边用中國Η家標毕(CNS)T4規格(2丨0X297公龙) 209835 Λ 6 Π 6 五、發明説明(丨<) 經沭部中央榀準局A工消伢合作杜印製 平均被水解之焦磷酸(撤克/毫升) 無抑制劑之 反應時間(分鐘) 對照組 加PVME/MA如PVPA 4.0 20.53 7.94 4.62 3.0 27.04 7.92 5.28 資料顯示PVPA對鹸性去磷酸酶抑制成效較PVHE/ HA為大 Ο 資料2 在活體中抗結石之效果 在老鼠結石研究中測試水及指示的溶液之結果於下 表2中: 平均結石面積 處理 嚴重性指樣土標準誤差 %變化 Α.水 61.8(± 10.4) Β . 6 · 2% Κ4 Ρ, 〇7 1* PVPA + 0.24% NaF 27 , 8(土 8.6) -55¾ 很明顯地處理方式B在活體中對抗結石之形成十分 具有效果。 老鼠結石研究敘述如下: -17 - (請先閲讀背而之注意事項再項寫本頁) 本紙Λ尺度逍用中B國家«準(CNS) T 4規格(2]0乂297公;it) 209835 A 6 η 6 五、發明説明(丨t) 2 1天大的雄性wm ling Sprogue-Dawley老鼠随意 分成含12隻老鼠之處理群。動物飼以産生結石之飼料 (RC-16)及去離子水於整傾研究期間。實驗處理開始前 所有動物以 S. mutants ( 6715 )及 A· viscosus (OMZ-105-Hn)懸浮液接種以剌激牙斑及結石的形成。老 鼠毎天(除了週末)用一自動吸管以0.2毫升溶液處理 一次。 此實驗為盲導性,處理方式樣以密碼且不為牽涉人 員所知。老鼠於處理21天後殺死並製備下顎根據例行方 法(SPI Τ0Χ 626)評置。開始及犧牲時之醱重予以記錄 (請先閲請背而之注意事項#填寫本頁) 經濟部中央標準局只工消费合作杜印製 〇 每 隻 老 鼠 上 頜 骨 與 下頜 费 象 限内 的 結 石 使 用 Br i n e r 及 Fr an c i s在” 鈣化組餓研究” , 卷1 1 . 1 0- 2 2 頁 9 1 9 7 3 年 , 發 表 之 方 法 加 以 評 估, 其 中 描述 結 石 表 面 積 嚴 重性指 標 (CSSI ) 〇 使 用 AN0VA加上S t U dent -N e w is a η - Ke n u Is試驗 進 行 資 料 之 統 計 性 分 析。 實 例 3 製 備 下 列 之 牙 音 • A B C D 水 ( 去 離 子 的 ) 4 2 .4 2 27 .4 6 2 6 . 14 20.12 甘 油 25 .0 0 10 .0 0 1 0 . 00 25.00 山 梨 醇 (70% ) - 25 .0 0 25 . 0 0 - 聚 乙 二 醇 6 0 0 - 3 .0 0 3 . 0 0 - 焦 磷 酸 四 納 2 .0 1 .5 0 - - 裝- 訂- 線· 本紙5艮尺度边用中國困家標毕(CNS)T4規格(210x297公《:) 209835 Λ 6 Π 6 經濟部中央標準局κχ工消t合作杜印製 五、發明説明(1) 裂備下列之牙膏: A B C D 焦磷酸四鉀 - 4.00 - - 三聚磷酸納 - - 6.00 - 六偏磷酸納 - - - 6.00 Xant han 1.50 - - 1.50 羧乙基鐵維納 - 1.20 1.20 - 氣代矽增厚劑 3.00 - .- 3.00 (Syloid 244) PVPA 0.50 0.50 1.00 0.50 單氟磷酸鈉 0.76 - 0.76 0.76 氟化紡 - 0.24 .- - 包含於矽氣化物之聪合 鋁(Zeo 49B) 21.50 - "" - 膠態矽氧化物(Zodent 113) - 23.00 23.00 - 焦磷酸鈣 - - - 40.00 苄酸納 2.50 2.50 0.50 0.50 二氣化鈦 0.50 0.30 0.30 0 .30 甜精納 0.30 0.30 0.30 0.30 芳香劑 1.00 1.00 1.00 1.00 月桂酵硫酸鈉 1.20 1.20 1.20 1.20 氫氣化鈉(50%) 0.32 0.30 0.60 0.32 19 - 本紙Λ尺度边用中國Β家梂毕(CNS) Τ4規格(210X297公;Jt) (請先閲讀背而之注意事項#攝寫本頁) 裝·
線:.I 209835 Λ 6 Π 6 五、發明説明(丨ι) 實例4 < 製備下列之漱口藥水·· 部份 A B 乙二醇 10.00 10.00 甘油 10.00 10.00 甜精納 0.03 0.03 阻斷性聯多元體 2 . 0 0 2 . 0 0 pluronic F 1 0 8 焦磷酸四鈉 2.00 1.00 焦磷酸四鉀 - 1.00 焦磷酸二鈉 - 0 . 10 PVPA 0.05 0.05 單氟磷酸納 0.15 0.15 芳香劑 0.40 0.40 水 加到1 0 0 . 0 0 加到1 0 0 . 0 0 (請先閱讀背而之注意事項再璜寫本頁) 裝- 訂- 線. 經濟部屮央標準局cs:工消f合作杜印製 本紙張尺度边用肀a困家i?準(CNS)肀4規格(210X297公;》:) 209835 Λ 6 Β 6 (五、發明説明(Ί 經來部中央榣準局只工消费合作杜印驳 實 例 5 錠 劑 糖 78-98 水 飴 1-20 芳 香 油 0 . 1- 1 . 0 錠 劑 潤 m 劑 0.1-5 聚 m 酸 0.1-5 氟 化 納 0.01-0.05 水 0.01-0.2 PVP A 0.05-3 寘 例 6 口 香 糖 暖 原 10 至 50 附 著 劑 3至10 填 充 m ( 山 梨 醇、甘 5至80 露 酵 或 上 述 之 聯合) 人 口 甘 味 0 . 1至 5 聚 m 酸 0 . 1至 5 PVPA 0 . 1 至 1 . 0 氟 化 銷 0.01至 0.05 芳 香 劑 0 . 1至 0 . 5 -21- 本紙ft尺度边用中Η «家榀毕(CNS)<p4規怙(2丨0x297公;《:) (請先閲讀背而之注意事項再填艿本頁) 裝_ 訂_ 線* icuooao 209835 Λ 6 _Π6_ ί 1 ,五、發明説明(/) 本發明已敘述柑開之一些偏好之具醱事實且可瞭解 的是其中對嫻於此技藝者而言很明顯之修正及變化被包 含於此專利之範圍及附加之申請專利範圍中。 (請先間讀背而之注意事項#项寫本頁) 裝- 訂- 線- 經濟部屮央榀準局CS:工消#合作社印Μ 本紙張尺度边用中B國家標毕(CNS)T4規«5(210X297公;It)
Claims (1)
- 丨桷充 馭.'曰、申請專利範園 專利申諳茶第811〇σ434 ^ ROC Patent Appln. Ho.81100434 修正之申請▼利g圍中文本-拼件H Aaended Claims in Chinese - Enel.I. (民國82年 6月 12曰送呈) (Subaitted on June 12 ,1993) 1. 一種口腔罔组成物,其可抑制無定形磷酸鈣鞞變成通常舆结 石有期之羥基磷灰石(HAP)结晶構造v其在一口腔可接受之載醱中•包括 有效抗结石費之至少一锺作為基本抗结石劑之線狀分子去水 ,聚读铉轻.及有效量之於唾.液中Μ至多约4X對抗該抗结石劑 之鲜紊水解之合成陰雔子性膦眩聚乙烯酯抑制劑,其具以下 之重復基国 •CHa - CHa HO - P = 0 (請先閱讀背面之注意本項再填窝本頁) •疚· •打·_·· 經 濟 部 + 央 櫟 準 貝 工 消 费 合 作 社 印 製 及约1000及更大之平均分子蛋;且其中H及Hx為® .龄金屬 或技,且其中Η及1為相同或相異,其中存在有一氟雔子來海 •其足以提供约25-100 0 ppm'之無萑性箱;朗子含贵以作為一锺 抗圉炷劑及作為對抗己述基本抗结石剞之酵苤性水解之進~ 步仰制剞。 2.如申請專利範圍第1項之口腔用组成物•其中膦眩聚乙烯酷 之含置约為重量百分率0.05-«。 -23 - •線. 本紙張尺度適用中國國家標準(CNS) f 4規格(210x297公釐) 經濟部中央標準局貝工消费合作社印製 V 209835 & C7 ___D7_' 六、申請專利範圊 3 .如申的玛利範圆第1或2項之口腔用姐成物,其中 Μ貼52乙烯S3具約1 0 0 0至1 , 0 0 0 , 〇 β 0之分子贵。 4 .如申葫母利铊圊第1或.2項之口腔用組成物•其中 之賧卽Κ乙始Μ再约6 , 0 0 0至U 0 , Q 0 Q之分子瓜。 5 .如申⑽玛利盹固第3項之口腔用紐成物,其中之膦 的聚乙烯δ§之含約為ffi S百分率〇 . 〇 5 - 3 %。 6 .如Φ訪毋利盹囡笫5項之口腔川纽成物,其中膦的 K乙烯酯之含S约為ffl S百分率η . 1 - 2 %。 '7 .如申諒玛利盹囡第1或2項之口腔用姐成物,其中 之52 51¾ 15之含fi约為mfi百分率0.1-7 %。 3,如申β専利钮囡第1或2項之口腔用姐成物,其中 之聚K肋S体运自六偏瞵敗19、三55明酸短、焦奶 迆S及其混合物。 9.如申玷專利绽囡第1或2項之口 K用組成物,其中 之聚较Ϊ3發偽g自焦晓K四钔、焦5TB3四ίΦ及.其 _ίϋ合物。 1 〇 .如申a邱利钝迆馆1或2項之口丨β用組成物,其中 之Κ Κ助盈之含毋约為ffi毋百分浓4 ·. 3 - 7 %且為妈 鸱頭四卯與焦的Βίΐ ω ίι1丨之κι合物,炖昭β3四鉀之含 毋垃超過炖的肋U扪的含毋。 11.如中訊玛利铊凼钔1項之口腔用纽成物,其中之浞 码邱®為焯奶03四m旦其含麗為約i丨i ft百分帘〇. 1 -z %。 \ -24- (請先閲讀背面之注意事項再填寫本頁) _襄· 本紙張尺度適用中國國家標準(CNS)甲4規格(210x297公货) 209835 A 7 B7 C7 D7 六、申請專利範® 1 2 ·如申Μ 之纪碟 1 3 .如屮£// 之聚砹 1 4 .如申詰 軾制包 一 a肢 剧且其 '性充光 1 5 .如申^ 亮剌為 ΊΓ 1 6 .如申詰 /之邮剤 對酵之 毋利铊圆第1或2项之q腔用組成物,其中 段盈為三聚明酸弪。 5?莉铊S铪1或2項之口腔用組成物,.其中 酸盛為六偏磷酸S。 玛利钮第.1或2項之口腔用组成物,丼中 括約SL贵1 〇 % - 9 ◦ %由水及削紐成之· DS戟劑及约佔ffl S卩.1 % — 1 0 %之一桠眧化 中SI S之1 〇 — 75 Z為一孤牙齒可接受之水溶 劑;这口腔用組成物為一诬牙讶。 專利钝囡第14項i 口腔用組成物,其中之光 一 Μ含矽之光亮劑。 邱利钮図第1或2項之口腔用组成物,其中 中约7 0 - 9.9 9 %之ffi fi為水—酵混合物,水 SSlib由约1: 1至2(3:1;这口 S2用組成物為 (請先閣讀背面之注素事項再填寫本頁) .襄. 經 濟 部 中 央 標 準 貝 工 消 费 合 作 社 印 製 一種街口椠水。 17. 如申Μ玛利铊囡铅1項 '之口腔/Π姐成物,丼中之侃 郎子來源係S自龄金藤佤化物及I金換W佤明即化' 物。 18. 如巾詰邛利钮囤第17項之口腔用姐成物,其中之佤 邮子來源為佤化钠。 2 5 本紙張尺度適用中國國家標準(CNS)甲4規格(210x297公漦) •綠.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/631,302 US5094844A (en) | 1990-12-20 | 1990-12-20 | Anticalculus oral composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TW209835B true TW209835B (zh) | 1993-07-21 |
Family
ID=24530627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW081100434A TW209835B (zh) | 1990-12-20 | 1992-01-22 |
Country Status (29)
Country | Link |
---|---|
US (1) | US5094844A (zh) |
EP (1) | EP0492997B1 (zh) |
JP (1) | JP3643382B2 (zh) |
KR (1) | KR100221157B1 (zh) |
CN (1) | CN1062463A (zh) |
AT (1) | ATE133853T1 (zh) |
AU (1) | AU649088B2 (zh) |
BR (1) | BR9105532A (zh) |
CA (1) | CA2057697C (zh) |
CZ (1) | CZ284259B6 (zh) |
DE (1) | DE69117034T2 (zh) |
DK (1) | DK0492997T3 (zh) |
FI (1) | FI916053A (zh) |
GR (1) | GR1001273B (zh) |
HK (1) | HK71297A (zh) |
HU (1) | HU212441B (zh) |
MX (1) | MX9102665A (zh) |
MY (1) | MY107462A (zh) |
NO (1) | NO180433C (zh) |
NZ (1) | NZ240914A (zh) |
PL (1) | PL167491B1 (zh) |
PT (1) | PT99817B (zh) |
RO (1) | RO110674B1 (zh) |
RU (1) | RU2092162C1 (zh) |
SG (1) | SG48983A1 (zh) |
SK (1) | SK279232B6 (zh) |
TW (1) | TW209835B (zh) |
YU (1) | YU195791A (zh) |
ZA (1) | ZA919580B (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368845A (en) * | 1993-01-07 | 1994-11-29 | Colgate Palmolive Company | Oral composition |
US5599527A (en) * | 1994-11-14 | 1997-02-04 | Colgate-Palmolive Company | Dentifrice compositions having improved anticalculus properties |
TR199801528T2 (xx) * | 1996-02-08 | 1998-11-23 | Warner-Lambert Company | Y�ksek derecede ��z�n�r pirofosfat i�eren, di� ta��na kar�� etkili di� temizli�i bile�imi. |
US6713049B1 (en) | 1999-11-12 | 2004-03-30 | The Procter & Gamble Company | Oral compositions providing optimal surface conditioning |
US6350436B1 (en) * | 1996-11-21 | 2002-02-26 | The Procter & Gamble Company | Method of reducing staining of stannous in dentifrice compositions |
US6190644B1 (en) * | 1996-11-21 | 2001-02-20 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and monofluorophosphate |
US20060171907A1 (en) * | 1996-11-21 | 2006-08-03 | The Procter & Gamble Company | Oral care compositions providing enhanced whitening and stain prevention |
US6241974B1 (en) * | 1997-04-22 | 2001-06-05 | The Procter & Gamble Company | Dentifrice compositions containing β-phase calcium pyrophosphate an anticalculus agent, and fluoride |
DE19740453A1 (de) | 1997-09-15 | 1999-03-18 | Henkel Kgaa | Zahnreinigungsmittel |
EP1041960B1 (en) | 1997-12-22 | 2002-07-17 | Ciba SC Holding AG | Use of polyanionic and polyanionically-derivatised natural polysaccharides for inhibiting alkaline phosphatase |
MXPA02004783A (es) | 1999-11-12 | 2002-08-30 | Procter & Gamble | Composiciones orales estannosas en dos fases mejoradas. |
US10470985B2 (en) | 1999-11-12 | 2019-11-12 | The Procter & Gamble Company | Method of protecting teeth against erosion |
JP3860471B2 (ja) | 1999-11-12 | 2006-12-20 | ザ プロクター アンド ギャンブル カンパニー | 改良された第1錫系口腔組成物 |
US20040146466A1 (en) | 1999-11-12 | 2004-07-29 | The Procter & Gamble Company | Method of protecting teeth against erosion |
US20070025928A1 (en) * | 1999-11-12 | 2007-02-01 | The Procter & Gamble Company | Stannous oral care compositions |
KR100382240B1 (ko) * | 2000-12-08 | 2003-04-26 | 주식회사 엘지생활건강 | 치석 및 치간 프라그 제거 효과가 우수한 치약 조성물 |
WO2002092027A2 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Confectionery compositions |
MXPA03010455A (es) | 2001-05-15 | 2004-03-09 | Procter & Gamble | Composiciones para el cuidado bucal. |
WO2002092037A1 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Oral care confectionery compositions |
US6361762B1 (en) * | 2001-05-21 | 2002-03-26 | Vi-Jon Laboratories, Inc. | Prebrushing liquid oral composition |
US9072658B2 (en) * | 2003-02-05 | 2015-07-07 | Fmc Corporation | Toothpaste compositions with reduced abrasivity |
KR100462465B1 (ko) * | 2003-11-20 | 2004-12-23 | 정천수 | 충방전 겸용잭을 갖는 충전지 케이스구조 및 이에연결되는 방수용 잭플러그 |
US20050271602A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Method for inhibiting chemical staining of teeth |
US20050271601A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Anti-staining antibacterial dentifrice |
US20070041914A1 (en) * | 2005-08-17 | 2007-02-22 | Colgate-Palmolive Company | Inhibition of bacterial deposition on oral surfaces |
KR100739996B1 (ko) * | 2005-09-30 | 2007-07-16 | 장정만 | 고 순도 규사를 이용한 액체치약 조성물과 제조방법 |
WO2012064341A1 (en) * | 2010-11-12 | 2012-05-18 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
BR112021008615A2 (pt) | 2018-11-07 | 2021-08-03 | The Procter & Gamble Company | composições para tratamento bucal compreendendo polifosfatos de comprimento médio |
US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
CN110559211B (zh) * | 2019-10-10 | 2022-05-20 | 重庆登康口腔护理用品股份有限公司 | 一种抑菌防龋组合物及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429963A (en) * | 1964-06-09 | 1969-02-25 | Colgate Palmolive Co | Dental preparation containing polymeric polyelectrolyte |
ZA717486B (en) * | 1970-11-19 | 1973-06-27 | Colgate Palmolive Co | Treatment of teeth |
US4138477A (en) * | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4427652A (en) * | 1980-12-31 | 1984-01-24 | Colgate-Palmolive Company | Antigingivitis composition |
US4816245A (en) * | 1983-12-28 | 1989-03-28 | Colgate-Palmolive Company | Antiplaque/antigingivitis method using certain polyphosphonic acids |
US4921692A (en) * | 1986-12-08 | 1990-05-01 | Colgate-Palmolive Company | Anticalculus oral composition |
US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
US4915937A (en) * | 1988-08-01 | 1990-04-10 | The Bf Goodrich Company | Dental antihydrolysis agent |
GB2224204B (en) * | 1988-10-25 | 1992-06-03 | Colgate Palmolive Co | Dental composition comprising polyvinyl phosphonic acid |
SE507731C2 (sv) * | 1988-12-29 | 1998-07-06 | Colgate Palmolive Co | Antibakteriell oral antiplaquekomposition |
-
1990
- 1990-12-20 US US07/631,302 patent/US5094844A/en not_active Expired - Lifetime
-
1991
- 1991-12-03 AU AU88814/91A patent/AU649088B2/en not_active Ceased
- 1991-12-04 ZA ZA919580A patent/ZA919580B/xx unknown
- 1991-12-07 MY MYPI91002270A patent/MY107462A/en unknown
- 1991-12-09 NZ NZ240914A patent/NZ240914A/xx not_active IP Right Cessation
- 1991-12-16 CA CA002057697A patent/CA2057697C/en not_active Expired - Fee Related
- 1991-12-16 PT PT99817A patent/PT99817B/pt not_active IP Right Cessation
- 1991-12-18 MX MX9102665A patent/MX9102665A/es unknown
- 1991-12-19 AT AT91311818T patent/ATE133853T1/de not_active IP Right Cessation
- 1991-12-19 NO NO915038A patent/NO180433C/no unknown
- 1991-12-19 PL PL91292865A patent/PL167491B1/pl not_active IP Right Cessation
- 1991-12-19 BR BR919105532A patent/BR9105532A/pt not_active Application Discontinuation
- 1991-12-19 HU HU914051A patent/HU212441B/hu not_active IP Right Cessation
- 1991-12-19 SG SG1996004822A patent/SG48983A1/en unknown
- 1991-12-19 DE DE69117034T patent/DE69117034T2/de not_active Expired - Fee Related
- 1991-12-19 DK DK91311818.8T patent/DK0492997T3/da active
- 1991-12-19 YU YU195791A patent/YU195791A/sh unknown
- 1991-12-19 KR KR1019910023761A patent/KR100221157B1/ko not_active IP Right Cessation
- 1991-12-19 RO RO148986A patent/RO110674B1/ro unknown
- 1991-12-19 EP EP91311818A patent/EP0492997B1/en not_active Expired - Lifetime
- 1991-12-19 RU SU5010396/14A patent/RU2092162C1/ru not_active IP Right Cessation
- 1991-12-19 GR GR910100506A patent/GR1001273B/el not_active IP Right Cessation
- 1991-12-20 SK SK3994-91A patent/SK279232B6/sk unknown
- 1991-12-20 JP JP33867791A patent/JP3643382B2/ja not_active Expired - Fee Related
- 1991-12-20 FI FI916053A patent/FI916053A/fi not_active Application Discontinuation
- 1991-12-20 CN CN91111742A patent/CN1062463A/zh active Pending
- 1991-12-20 CZ CS913994A patent/CZ284259B6/cs not_active IP Right Cessation
-
1992
- 1992-01-22 TW TW081100434A patent/TW209835B/zh active
-
1997
- 1997-05-29 HK HK71297A patent/HK71297A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW209835B (zh) | ||
JP2573685B2 (ja) | 抗歯石口腔用組成物 | |
US3962417A (en) | Dentifrice | |
DE69618786T2 (de) | Wärmeerzeugende zahnpasta | |
FR2587211A1 (fr) | Composition anti-tartre a usage buccal de polyphosphate, son procede de fabrication et procede l'utilisant | |
MXPA01010343A (es) | Producto dental anti-sarro y metodo relacionado. | |
US5073363A (en) | Foamable fluoride gels and method | |
JPS6330881B2 (zh) | ||
US4309410A (en) | Non-staining antigingivitis composition | |
US6022528A (en) | Oral compositions | |
JP4181279B2 (ja) | 義歯用歯みがきクリーム | |
JPH09500101A (ja) | 歯石抑制重曹歯磨剤の製造方法 | |
JPS62223109A (ja) | 安定な単位用量型口腔用製品 | |
GB2151478A (en) | Antiplaque/antigingivitis compositions | |
JP5845603B2 (ja) | 液体又は液状の口腔用組成物及び舌苔付着抑制剤 | |
JPS6043325B2 (ja) | 口腔用組成物 | |
US4139608A (en) | Oral compositions containing an anticalculus agent | |
JP2002316920A (ja) | 口腔用組成物 | |
CN114096225A (zh) | 包含姜二醇的口腔护理组合物及制备该组合物的方法 | |
JP2003342141A (ja) | 口腔用組成物 | |
JPS58216116A (ja) | 口腔用組成物 | |
NO860890L (no) | Oralt preparat mot tannstein. | |
Howard | Dental Preparations | |
JPH02184616A (ja) | 口内用組成物 |